Cardiac troponin T in coronary heart disease patients with chronic heart failure
Abstract
The study included 45 patients with coronary heart disease (CHD) and chronic heart failure (CHF) of functional class I-IV. Increased cardiac troponin T(cTnT) level could be used in verification and assessment of CHF decompensation severity. In CHF, increase in cTnT level was influenced by CHF decompensation, left ventricular systolic dysfunction and remodeling. At the same time, essential arterial hypertension, post-infarctial cardiosclerosis, permanent atrial fibrillation, left ventricular diastolic dysfunction, left atrium pathologic remodeling did not significantly influence cTnT concentration in patients with CHD and CHF.
About the Authors
V. S. Nikiforov
Российский государственный медицинский университет
Russian Federation
Russian Federation
A. I. Karpishchenko
Российский государственный медицинский университет
Russian Federation
Russian Federation
A. S. Svistov
Российский государственный медицинский университет
Russian Federation
Russian Federation
V. L. Pastushenkov
Российский государственный медицинский университет
Russian Federation
Russian Federation
E. A. Lobanova
Пермская государственная медицинская академия
Russian Federation
Russian Federation
References
1. Ansari M., Massie B.M. Heart failure: How big is the problem? Who are the patients? What does the future hold? Am. Heart J. 2003; 146: 1-4.
2. Goto Т., Takase H., Toriyama T., et al. Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart. 2003; 89: 1303-1307.
3. Missov E., Mair J. A novel biochemical approach to congestive heart failure: Cardiac troponin T. Am. Heart J. 1999; 138: 95-99.
4. Perna E.R., Масin S.M., Canella J.P. C., et al. High levels of troponin T are associated with ventricular remodeling and adverse in-hospital outcome in heart failure. Med Sci Monit. 2004; 10: CR90-CR95.
5. Panteghini M. Role and importance of biochemical markers in clinical cardiology. Eur. Heart J. 2004; 25: 1187-1196
6. Rao A.C.R., Collinson P.O., Rose A.J., et al. Prospective evaluation of the role of routine cardiac troponin T measurement to identify left ventricular ejection fraction < 40 % after first myocardial infarction. Heart. 2003; 89: 559-560.
7. Ricchiuti V., Zhang J., Apple F.S. Cardiac troponin I and T alterations in heart with severe left ventricular remodeling. Clin. Chem. 1997; 43: 990-995.
8. Sato Y., Taniguchi R., Makiyama T., et al. Serum cardiac troponin T and plasma brain natriuretic peptide in patients with cardiac decompensation. Heart. 2002; 88: 647-648.
9. Sato Y., Kita Т., Takatsu Y., et al. Biochemical markers of myocyte injury in heart failure. Heart. 2004; 90: 1110-1113.
10. Xue C., Yu H., Li R., et al. Clinical significance of serum cardiac troponin T in patients with congestive heart failure. Chin. Med. J. 2003; 116: 469-471.
11. Yan A.T., Yan R.T., Tan M., et al. Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients. Eur. Heart J. 2004; 25: 2006-2012.
Review
For citations:
Nikiforov V.S., Karpishchenko A.I., Svistov A.S., Pastushenkov V.L., Lobanova E.A. Cardiac troponin T in coronary heart disease patients with chronic heart failure. Russian Journal of Cardiology. 2005;(1):28-32. (In Russ.)
Views:
365
Email this article 